Alignment Healthcare (ALHC) had an impressive week, gaining over 18% to close at $6.29 per share. This strong upward movement was not limited to ALHC alone, as A.I.dvisor's analysis showed that all 16 stocks in the Managed Health Care Industry trended upwards, indicating a positive trend for the entire sector.
Looking specifically at ALHC's technical indicators, the Relative Strength Index (RSI) Oscillator is worth noting. The RSI moved out of oversold territory on April 24, which suggests a potential shift in the stock's trend from downward to upward. Traders may want to consider buying the stock or call options.
To gain a deeper understanding of the implications of this indicator, A.I.dvisor examined 15 similar instances where the RSI Oscillator left oversold territory, finding that in 12 of those cases, the stock moved higher. This gives a probability of 80% that ALHC's stock will continue to trend upward.
While technical indicators like the RSI Oscillator can provide valuable insights for traders, it's important to consider other factors as well, such as the company's financial performance. In this regard, ALHC's most recent earnings report shows promising signs.
For the fourth quarter of 2022, ALHC reported $294 million in revenue, a 34% increase from the previous year. The company's net income also saw a significant improvement, with a $9.8 million profit compared to a $15.1 million loss in the same period last year. These results suggest that the company is making positive strides towards profitability.
Furthermore, ALHC's outlook for the future is optimistic, with the company forecasting continued revenue growth in the range of 20-25% for the next fiscal year. This projection is supported by the company's recent expansion efforts, such as its acquisition of a Medicare Advantage plan in Texas.
ALHC's impressive performance this week, combined with a positive technical indicator and promising earnings report, make it an intriguing prospect for traders and investors alike. However, as with any investment, it's important to conduct thorough research and consider all relevant factors before making any decisions.
The 10-day RSI Oscillator for ALHC moved out of overbought territory on February 06, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 instances where the indicator moved out of the overbought zone. In of the 27 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 42 cases where ALHC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on February 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ALHC as a result. In of 64 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for ALHC turned negative on February 06, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 31 similar instances when the indicator turned negative. In of the 31 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALHC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ALHC broke above its upper Bollinger Band on January 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
ALHC moved above its 50-day moving average on January 13, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ALHC crossed bullishly above the 50-day moving average on January 15, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALHC advanced for three days, in of 231 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 193 cases where ALHC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ALHC's P/B Ratio (5.974) is slightly higher than the industry average of (3.063). ALHC's P/E Ratio (0.000) is considerably lower than the industry average of (17.509). ALHC's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.089). ALHC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (0.506) is also within normal values, averaging (0.684).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ManagedHealthCare